Dietary Supplements

Briefing: Dietary Supplements Purpose: Understanding which dietary supplements are most evidence-based for healthy aging, with a focus on brain function and cardiovascular health in adults 40–70.

Key Insights

• Creatine monohydrate is the one supplement in this content batch with a confident evidence base, though its relevance to your primary goals is only partial. The clinical literature supports creatine for improving muscle strength and hypertrophy in older adults — effects attributed to enhanced ATP regeneration and cellular hydration that may also promote protein synthesis. For brain health specifically, the same expert who endorses creatine for muscle describes the cognitive evidence as still requiring "a lot more exploration," so it should be treated as a watch-list candidate rather than a confirmed inclusion for that goal. Cardiovascular effects are not addressed at all in this source.

• The Protein Threshold to Building Muscle After 60 | Dr Brad Schoenfeld

• Your baseline diet may determine how much creatine supplementation actually moves the needle for you. Creatine stores in the body are built primarily through animal protein consumption, so vegans and vegetarians tend to have lower baseline levels and show stronger responses to supplementation. If you eat meat regularly, your response may be more modest — and roughly 30% of people are non-responders regardless of diet. This is a useful personalization filter: creatine is low-risk to trial, but the magnitude of benefit is not uniform.

• The Protein Threshold to Building Muscle After 60 | Dr Brad Schoenfeld

• This content batch does not answer your core question. The source material here is drawn from a muscle physiology context and makes no substantive contact with the cardiovascular or cognitive supplement landscape you're trying to map — areas where clinical trial data does exist for compounds like omega-3 fatty acids, magnesium, B vitamins (particularly for homocysteine management), and phosphatidylserine. Treating this briefing as a foundation for your regimen would leave the most important questions unaddressed. The absence of evidence here is a gap in the source set, not a signal that these categories lack evidence.

• The Protein Threshold to Building Muscle After 60 | Dr Brad Schoenfeld

Emerging Patterns

No meaningful cross-source patterns can be identified in this batch — all content originates from a single source. This section is omitted; its absence reflects the narrow source set, not a lack of relevant patterns in the broader supplement literature.

Dissenting Views

No meaningful dissent exists within this source set. The one internal tension — creatine's strong muscle evidence versus its preliminary cognitive evidence — reflects a single expert's calibrated uncertainty rather than a cross-source disagreement. This section is omitted accordingly.

Read & Act

What to read

• The Protein Threshold to Building Muscle After 60 | Dr Brad Schoenfeld — Worth watching specifically for how Schoenfeld tiers his confidence: strong endorsement for creatine on muscle, explicit hedging on brain health. That approach — distinguishing "good efficacy in the literature" from "needs more exploration" — is exactly the evaluative framework you should apply when assessing supplements for brain and cardiovascular goals. Skip to the creatine discussion; the protein mechanics are background context rather than actionable for your stated goals.

What to do

• Run a structured 8-week creatine trial before expanding your regimen further. Creatine monohydrate is the only supplement here with a strong evidence base, a well-understood safety profile, and emerging (if unconfirmed) cognitive signals — making it a reasonable low-risk starting point while you gather better sources on cardiovascular and brain-specific compounds. A standard dose of 3–5g daily is what the clinical literature typically uses; no loading phase is necessary for the purposes of a personal trial. Track a simple proxy — workout performance, energy, or subjective cognitive clarity — to get a personal read on whether you're a responder before committing long-term.

• Prioritize sourcing clinical trial data on omega-3s, B vitamins, and magnesium before finalizing any regimen. These are the cardiovascular and cognitive supplement categories with the deepest clinical trial literature for the 40–70 age group, and they are entirely absent from this content batch. Search specifically for meta-analyses or systematic reviews (not individual studies) on each compound for your target outcomes — cardiac event reduction, homocysteine management, and cognitive decline prevention — so that when you do expand your regimen, each addition is justified by the same standard of evidence Schoenfeld applies to creatine for muscle.